Skip to content
Company Analysis

Tilray Brands, Inc. TLRY

A comprehensive view of key metrics, scores, and financial health for Tilray Brands, Inc.

Overview of Tilray Brands, Inc.

TLRY NMS
Healthcare Drug Manufacturers - Specialty & Generic Small Cap
Tilray Brands, Inc. (TLRY), is a Small Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $6.89, about 0.0% overvalued vs fair value, +7.7% 1Y return, ranked 853/1110 in sector.
$6.89
-0.86%
As of March 13, 2026
Previous close • Vol 90d: 107.9%
52-Week Range
Market Cap
$840.01M
Enterprise Value
$912.94M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Tilray Brands, Inc..

Top Beats

Quick Facts

Website https://www.tilray.com
HQ Leamington, ON
Employees 2,842
Fiscal year May 31

Next Events

Earnings Apr 8 Estimated

Fair Value Snapshot

Bear Base Bull
$-18
$-17
$-15
Current: $6.89

Engine Room Money Flow™

Small Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$821.3M
4.1%%
Gross Profit
$240.6M
7.7%%
R&D Expense
$284.0K
-55.3%%
Operating Income (EBIT)
$-2.3B
-1031.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

R&D Intensity
0.0%
Fair

Lower R&D intensity - may indicate mature portfolio or cost cuts

Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$1.5M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Tilray Brands, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
39
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
44
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 91% Coverage
Trade-Off Triangle Visualization A ternary plot showing TLRY's balance between Growth (39.5%), Profitability (24.4%), and Safety (36.2%). Growth 39% Safety 36% Profitability 24%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

37th percentile vs peers
38
Key Signals
Revenue CAGR 3Y 9.3% 59p Rev Growth YoY 4.1% 45p TSR -59.9% 31p EPS Growth YoY -5.76 3p
Strengths

No notable strengths identified for this axis.

Risks
  • Eps Growth Yoy in bottom 20% of peers (-5.76)

Profitability

23th percentile vs peers
23
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

34th percentile vs peers
35
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Tilray Brands, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-16.64
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info